Rapid Micro Biosystems (RPID) Interest & Investment Income (2024 - 2026)
Rapid Micro Biosystems (RPID) reported Interest & Investment Income of $256000.0 for Q1 2026, down 45.06% on a YoY basis from $466000.0 in Q1 2025, and down 31.73% sequentially from $375000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Interest & Investment Income (2024 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 3 years of Interest & Investment Income data on file, last reported at $256000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 45.06% year-over-year to $256000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (changed N/A YoY), and the FY2025 full-year result was $1.5 million, down 52.9% from the prior year.
- Interest & Investment Income declined to $256000.0 in Q1 2026, from $375000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $779000.0 in Q3 2024 to a low of $256000.0 in Q1 2026.
- A 3-year average of $468333.3 and a median of $420500.0 in 2025 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 36.12% in 2025, while the deepest fall reached 55.46% in 2025.
- Tracing RPID's Interest & Investment Income over 3 years: stood at $587000.0 in 2024, then slumped by 36.12% to $375000.0 in 2025, then slumped by 31.73% to $256000.0 in 2026.
- Business Quant data shows RPID's Interest & Investment Income at $256000.0 in Q1 2026, $375000.0 in Q4 2025, and $347000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Rapid Micro Biosystems | 89.73 Mn | 80.30 Mn | 371,000.00 | 256,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 256,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Sep 30, 2025 | 347,000.00 |
| Mar 31, 2025 | 466,000.00 |
| Dec 31, 2024 | 587,000.00 |
| Sep 30, 2024 | 779,000.00 |